Ortek CaviStat Anticaries Ingredient Approval To Be Sought By Late 2003
This article was originally published in The Rose Sheet
Executive Summary
Ortek Therapeutics expects to apply for FDA approval of its arginine/bicarbonate/calcium carbonate anticaries ingredient CaviStat by the end of the year